- Home
- ZYXI vs ZURA Comparison
ZYXI vs ZURA Comparison
Compare ZYXI & ZURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZYXI
- ZURA
- Stock Information
- Founded
- ZYXI 1996
- ZURA 2022
- Country
- ZYXI United States
- ZURA United States
- Employees
- ZYXI N/A
- ZURA N/A
- Industry
- ZYXI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- ZURA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ZYXI Health Care
- ZURA Health Care
- Exchange
- ZYXI Nasdaq
- ZURA Nasdaq
- Market Cap
- ZYXI 66.5M
- ZURA 76.6M
- IPO Year
- ZYXI N/A
- ZURA N/A
- Fundamental
- Price
- ZYXI $2.02
- ZURA $1.01
- Analyst Decision
- ZYXI Buy
- ZURA Buy
- Analyst Count
- ZYXI 3
- ZURA 7
- Target Price
- ZYXI $6.00
- ZURA $14.33
- AVG Volume (30 Days)
- ZYXI 176.4K
- ZURA 517.4K
- Earning Date
- ZYXI 07-24-2025
- ZURA 05-08-2025
- Dividend Yield
- ZYXI N/A
- ZURA N/A
- EPS Growth
- ZYXI N/A
- ZURA N/A
- EPS
- ZYXI N/A
- ZURA N/A
- Revenue
- ZYXI $172,401,000.00
- ZURA N/A
- Revenue This Year
- ZYXI N/A
- ZURA N/A
- Revenue Next Year
- ZYXI $19.55
- ZURA N/A
- P/E Ratio
- ZYXI N/A
- ZURA N/A
- Revenue Growth
- ZYXI N/A
- ZURA N/A
- 52 Week Low
- ZYXI $1.66
- ZURA $0.97
- 52 Week High
- ZYXI $10.62
- ZURA $5.50
- Technical
- Relative Strength Index (RSI)
- ZYXI 40.53
- ZURA 35.69
- Support Level
- ZYXI $2.21
- ZURA $0.99
- Resistance Level
- ZYXI $2.66
- ZURA $1.06
- Average True Range (ATR)
- ZYXI 0.20
- ZURA 0.08
- MACD
- ZYXI 0.02
- ZURA -0.01
- Stochastic Oscillator
- ZYXI 5.19
- ZURA 9.02
About ZYXI Zynex Inc.
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company operates business as one operating segment which includes two revenue types: Devices and Supplies. Its markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.
About ZURA Zura Bio Limited
Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.